The US Food and Drug Administration (FDA) has approved Anbogen Therapeutics’ investigational new drug (IND) application for ...

Importers can now apply, track, and receive approval for their drug consignments via an integrated digital portal, ...

Health Canada is supposed to issue rulings on new generics – which are copies of branded drugs whose patents have expired – ...

Gireesh Babu, New Delhi Tuesday, August 5, 2025, 08:00 Hrs [IST] ...

The IND application of IBI3032 was accepted by China’s National Medical Products Administration (NMPA) and approved by the U.S. Food and Drug Administration (FDA). A multi-regional Phase 1 clinical ...

SHELTON, CT / ACCESS Newswire / July 30, 2025 / NanoViricides, Inc., a publicly traded company (NYSE Amer.:NNVC) (the ...

Pharmaceutical company Novartis is suing the Oregon Board of Pharmacy to stop a new state law that would expand how safety-net providers can get discounted prescription drugs. The dispute centers on ...

Sanofi secures exclusive rights to develop plozasiran in Greater China, enhancing treatment options for hypertriglyceridemia ...

The FDA is expected to decide on treatments for acromegaly, edema, HSCT-associated thrombotic microangiopathy, multiple sclerosis, and spinal muscular atrophy.

Researchers at the University of Bath have developed a new technology that—for many patients—could make injections a thing of ...

The program has been transitioned to a permanent pathway that is designed to support innovative tools like artificial intelligence, wearables, and biomarkers in drug development and trials.

The FDA approved an investigational new drug application for ABT-301, clearing the way for a new clinical trial in metastatic ...